Terms ending in 2029
Every in-force patent on Merck & Cie's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,377,756 | 18F-LABELLED Folates In force · High confidence | Merck & Cie | In force | High confidence | |
| US 8,021,529 | Ion Measurement/Calibration Cell In force · High confidence | Merck & Cie | In force | High confidence | |
| US 9,315,506 | 18F-LABELLED Folates In force · High confidence | Merck & Cie | In force | High confidence | |
| US 9,180,128 | Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate In force · High confidence | Merck & Cie | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.